Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Recent clinical and pathophysiological advances in non-functioning pituitary adenomas.

Korbonits M, Carlsen E.

Horm Res. 2009 Apr;71 Suppl 2:123-30. doi: 10.1159/000192449. Epub 2009 Apr 29. Review.

PMID:
19407508
2.

Galectin-3 as a marker distinguishing functioning from silent corticotroph adenomas.

Thodou E, Argyrakos T, Kontogeorgos G.

Hormones (Athens). 2007 Jul-Sep;6(3):227-32.

3.

Effects of selective somatostatin analogs and cortistatin on cell viability in cultured human non-functioning pituitary adenomas.

Padova H, Rubinfeld H, Hadani M, Cohen ZR, Nass D, Taylor JE, Culler MD, Shimon I.

Mol Cell Endocrinol. 2008 May 14;286(1-2):214-8. doi: 10.1016/j.mce.2007.12.011. Epub 2007 Dec 27.

PMID:
18276067
4.

p75 and TrkC neurotrophin receptors demonstrate a different immunoreactivity profile in comparison to TrkA and TrkB receptors in human normal pituitary gland and adenomas.

Assimakopoulou M, Zolota V, Chondrogianni C, Gatzounis G, Varakis J.

Neuroendocrinology. 2008;88(2):127-34. doi: 10.1159/000119743. Epub 2008 Mar 5.

PMID:
18319596
5.

Estrogen receptors in human pituitary tumors.

Burdman JA, Pauni M, Heredia Sereno GM, Bordón AE.

Horm Metab Res. 2008 Aug;40(8):524-7. doi: 10.1055/s-2008-1065338. Epub 2008 Apr 9.

PMID:
18398784
6.

Neuronal differentiation and expression of neural epitopes in pituitary adenomas.

Johnson MD, Fan X, Bourne P, Walters D.

J Histochem Cytochem. 2007 Dec;55(12):1265-71. Epub 2007 Sep 17.

PMID:
17875653
7.

Somatostatin receptors in pituitary function, diagnosis and therapy.

Hofland LJ, Lamberts SW.

Front Horm Res. 2004;32:235-52. Review.

PMID:
15281350
8.

[Pituitary carcinoma. Anatomic and clinical features of cases reported in literature].

Sidibé EH.

Neurochirurgie. 2007 Aug;53(4):284-8. Review. French.

PMID:
17524431
9.

"Silent"corticotropinoma.

Pawlikowski M, Kunert-Radek J, Radek M.

Neuro Endocrinol Lett. 2008 Jun;29(3):347-50.

PMID:
18580839
10.

O-6-methylguanine-DNA methyltransferase (MGMT) immunohistochemical expression in pituitary corticotroph adenomas.

Salehi F, Scheithauer BW, Kovacs K, Horvath E, Syro LV, Sharma S, Manoranjan B, Cusimano M.

Neurosurgery. 2012 Feb;70(2):491-6; discussion 496. doi: 10.1227/NEU.0b013e318230ac63.

PMID:
21822153
11.

Survivin products in pituitary tumors.

Jankowska A, Wasko R, Waligorska-Stachura J, Andrusiewicz M, Jaskula M, Liebert W, Sowinski J.

Neuro Endocrinol Lett. 2008 Dec;29(6):1033-7.

PMID:
19112393
12.

Nonfunctioning adenomas of the pituitary.

Liuzzi A, Tassi V, Pirro MT, Zingrillo M, Ghiggi MR, Chiodini I, Oppizzi G, Barberis M.

Metabolism. 1996 Aug;45(8 Suppl 1):80-2. Review.

PMID:
8769390
13.

Pituitary tumors: diagnosis, management, and implications for reproduction.

Beshay VE, Beshay JE, Halvorson LM.

Semin Reprod Med. 2007 Sep;25(5):388-401. Review.

PMID:
17710735
14.

[New developments in pituitary diseases].

Gruber M, Willenberg HS, Bornstein SR.

Dtsch Med Wochenschr. 2012 Dec;137(49):2540-2. doi: 10.1055/s-0032-1327285. Epub 2012 Nov 27. Review. German. No abstract available.

PMID:
23188633
15.

Clinical features of silent corticotroph adenomas.

Alahmadi H, Lee D, Wilson JR, Hayhurst C, Mete O, Gentili F, Asa SL, Zadeh G.

Acta Neurochir (Wien). 2012 Aug;154(8):1493-8. doi: 10.1007/s00701-012-1378-1. Epub 2012 May 24.

PMID:
22619024
16.

Clinically non-functioning human pituitary adenomas.

Asa SL, Kovacs K.

Can J Neurol Sci. 1992 May;19(2):228-35. Review.

PMID:
1623451
17.

Non-functioning pituitary adenomas.

Chanson P, Brochier S.

J Endocrinol Invest. 2005;28(11 Suppl International):93-9. Review.

PMID:
16625856
18.

Silent corticotroph adenomas.

Karavitaki N, Ansorge O, Wass JA.

Arq Bras Endocrinol Metabol. 2007 Nov;51(8):1314-8. Review.

19.

Clinically silent somatotroph adenomas are common.

Wade AN, Baccon J, Grady MS, Judy KD, O'Rourke DM, Snyder PJ.

Eur J Endocrinol. 2011 Jul;165(1):39-44. doi: 10.1530/EJE-11-0216. Epub 2011 Apr 14.

20.

High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosome 12 polysomy.

Pierantoni GM, Finelli P, Valtorta E, Giardino D, Rodeschini O, Esposito F, Losa M, Fusco A, Larizza L.

Endocr Relat Cancer. 2005 Dec;12(4):867-74.

Supplemental Content

Support Center